Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma

  • 27 Accesses

  • 8 Citations

Summary

Tumor antigen (TA) associated with the canine transmissible venereal sarcoma (CTVS) was detected in the sera of dogs bearing the tumor. Rabbit antisera specific for tumor antigen and 3 M KCl extracts of CTVS cells were used in both a competitive enzyme-linked immunosorbent assay (ELISA) and antigen-capture ELISA to quantify levels of circulating TA. In a study of 29 dogs bearing the transplanted CTVS, levels of circulating TA correlated positively with tumor volume. In a longitudinal study of four dogs receiving a transplant of 108 viable CTVS cells, circulating CTVS antigen was detected transiently 2 days after transplantation, while persistent levels of TA associated with increasing tumor volume were demonstrable 19–34 days after transplantation. In three of four tumor-bearing dogs, levels of serum TA correlated inversely with values obtained with peripheral blood leukocytes in the leukocyte adherence inhibition (LAI) assay; elevated levels of circulating TA found in dogs with large (>7 cm3) tumors were associated with decreased LAI reactivity of peripheral blood leukocytes. TA could not be detected in sera 48–72 h after surgical removal of CTVS whereas LAI reactivity of peripheral blood leukocytes to CTVS antigen rebounded 1–3 weeks following tumor excision. Results of this study support the use of the competitive ELISA and LAI techniques in assessing levels of circulating tumor antigen, tumor burden and tumor-specific immunity.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Baldwin RW, Robins RA (1976) Factors interfering with immunological rejection of tumors. Br Med Bull 32: 118–123

  2. 2.

    Baldwin RW, Price MR, Robins RA (1972) Blocking of lymphocytemediated cytotoxicity for rat hepatoma cell by tumor-specific antigen-antibody complexes. Nat New Biol 238: 185–187

  3. 3.

    Baldwin RW, Price MR, Robins RA (1973) Inhibition of hepatomaimmune lymph-node cell cytotoxicity by tumor-bearer serum and solubilized hepatoma antigen. Int J Cancer 11: 527–535

  4. 4.

    Black P (1980) Shedding from the cell surface of normal and cancer cell. Adv Cancer Res 32: 75–199

  5. 5.

    Bonavida, B (1973) Studies on the induction and expression of T-cell mediated immunity. I. Blocking of cell-mediated cytolysis by membrane antigens. J Immunol 12: 926–934

  6. 6.

    Bray KR, Koda JE, Gaur PK (1987) Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker. Cancer Res 47: 5853–5860

  7. 7.

    Cohen D (1973) The biological behavior of the transmissible venereal tumor in immunosuppressed dogs. Eur J Cancer 9: 253–258

  8. 8.

    Cohen D (1985) The canine transmissible venereal tumor: a unique result of tumor progression. Adv Cancer Res 43: 75–112

  9. 9.

    DeMonbreun WA, Goodpasture EW (1934) Experimental investigation concerning the nature of contagious lymphosarcoma of dogs. Am J Cancer 21: 295–321

  10. 10.

    Grosser N, Marti JH, Proctor JW, Thomson DMP (1976) Tube leukocyte adherence inhibition assay for the detection of anti-tumor immunity. I. Monocyte is the reactive cell. Int J Cancer 18: 39–47

  11. 11.

    Harding MW, Yang TJ (1981) Canine transmissible venereal sarcoma: leukocyte adherence inhibition (LAI) reactivity of various lymphoid tissues of dogs with tumors of different stages of growth. Int J Cancer 27: 349–355

  12. 12.

    Harding MW, Yang TJ (1981) Sequential changes in peripheral blood leukocyte adherence inhibition (LAI) reactivity during progressive growth and spontaneous regression of canine transmissible venereal sarcoma. Int J Cancer 28: 361–366

  13. 13.

    Harding MW, Yang TJ (1984) Amplification of lymph node cell leukocyte adherence inhibition (LAI) reactivity by leukocyte adherence inhibition factor (LAIF) Cell Immunol 87: 206–216

  14. 14.

    Harding MW, Yang TJ (1985) Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS). Cancer Immunol Immunother 19: 168–176

  15. 15.

    Hayes DF, Zurawski VR Jr, Kuf DW. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol 4: 1542–1550

  16. 16.

    Hellstrom KE, Hellstrom I (1978) Evidence that tumor antigens enhance tumor growth in vivo by interacting with a radiosensitive (suppressor?) cell population. Proc Natl Acad Sci USA 75: 436–445

  17. 17.

    Herlyn M, Shen JW, Sears HF, Civin CI, Verrill HL, Goldberg EM, Koprowski H (1984) Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants. Clin Exp Immunol 55: 23–35

  18. 18.

    Herlyn M, Rodeck U, Koprowski H (1989) Shedding of human tumor associated antigens in vitro and in vivo. Adv Cancer Res 49: 189–221

  19. 19.

    Kalb VF, Bernlohr RW (1977) A new spectrophotometric assay for protein in cell extract. Anal Biochem 82: 362–371

  20. 20.

    Karlson AG, Mann FC (1952) The transmissible venereal tumor of dogs: observations over forty generations of experimental transfers. Ann NY Acad Sci 54: 1197–1213

  21. 21.

    Komada Y, Ochiai H, Shimizu K, Azuma E, Kamiya H, Sakurai M (1987) Shedding of leukemia-associated P24 antigen by lymphoblastoid cell lines. J J Clin Oncol 17: 333–342

  22. 22.

    Ladisch S, Kitada S, Hays EF (1987) Gangliosides shed by tumor cells enhance tumor formation in mice. J Clin Invest 79: 1879–1882

  23. 23.

    Leoni F, Bast RC Jr, Canevari S, Menard S, Soper JT, Colnaghi MI (1987) Immunochemical characterization and radioimmunometric detection of molecules shed by human ovarian cancer. Int J Cancer 40: 592–597

  24. 24.

    Lopez MJ, O'Connor R, MacFarlane JK, Thomson DMP (1978) Abrogation of the phenomenon of leukocyte adherence inhibition by excess tumor antigen. Br J Cancer 38: 660–673

  25. 25.

    Losa GA, Heumann D, Carrel S, von Fliedner V, Mach JP (1986) Characterization of membrane vesicles circulating in the serum of patients with common acute lymphoblastic leukemia. Lab Invest 55: 573–579

  26. 26.

    Markwell MAK, Haas SM, Bieber LL, Tollbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206–210

  27. 27.

    Marti JH, Grosser N, Thomson DMP (1976) Tube leukocyte adherence inhibition for the detection of anti-tumor immunity: II. Monocyte reacts with tumor antigen via cytophilic anti-tumor antibody. Int J Cancer 18: 48–57

  28. 28.

    Matsunaga A, Kuroki M, Higuchi H, Arakawa F, Takakura K, Okamoto N, Matsuoka Y (1987) Antigenic heterogeneity of carcinoembryonic antigen in the circulation defined by monoclonal antibodies against the carbohydrate moiety of carcinoembryonic antigen and closely related antigens. Cancer Res 47: 56–61

  29. 29.

    Nakane PK, Kawaoi A (1974) Peroxidase labeled antibody. A new method of conjugation. J Histochem Cytochem 22: 1084–1091

  30. 30.

    Novinsky MA (1876) Zentralbl Med Wiss 14: 790–971

  31. 31.

    Palker TJ, Yang TJ (1981) Identification and physico-chemical characterization of a tumor-associated antigen from the canine transmissible venereal sarcoma. J Natl Cancer Inst 66: 779–787

  32. 32.

    Palker TJ, Yang TJ (1985) Detection of immune complexes in sera of dogs with the canine transmissible venereal sarcoma (CTVS) by a conglutinin binding assay. J Comp Pathol 95: 247–258

  33. 33.

    Shenouda G, Thomson DMP (1984) Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to class I major histocompatibility gene products in the leukocyte adherence inhibition assay. Cancer Res 44: 2762–2768

  34. 34.

    Slaght SS, Yang TJ, van der Heide L (1979) Adaptation of enzymelinked immunosorbent assay to the avian system. J Clin Microbil 10: 698–702

  35. 35.

    Swenson, JJ (1977) Physiological properties and cellular and chemical constituents of blood. In: Swenson MJ (ed) Duke's physiology of domestic animals, Cornell University Press, Ithaca, NY, 32

  36. 36.

    Thomson DMP (1982) The LAI response to human cancer: the biology of the LAI response and features of the antigens. In: Thomson DMP (ed) Assessment of immune status by the leukocyte adherence inhibiton test, Academic Press, New York, pp 128–166

  37. 37.

    Thomson DMP, Grosser N (1979) Immunologic mechanism of tube leukocyte adherence inhibition. Cancer Res 39: 576–581

  38. 38.

    Thomson DMP, Tataryn DN, Schwartz R, MacFarlane JK (1979) The natural history of antitumor immunity in human breast cancer assayed by tube leukocyte adherance inhibition. Eur J Cancer 15: 1095–1106

  39. 39.

    Thomson DMP, Phelon J, Morton DG, Bach MK (1982) Armed human monocytes challenged with a sensitizing cancer extract release substances pharmacologically similar to leukotrienes. Int J Cancer 30: 229–306

  40. 40.

    Vennegoor C, Rumke P (1986) Circulating melanoma-associated antigen detected by monoclonal antibody NKI/C-3. Cancer Immunol Immunother 23: 93–100

  41. 41.

    Yang TJ, Jones JB (1973) Canine transmissible venereal sarcoma: transplantation studies in neonatal and adult dogs. J Natl Cancer Inst 51: 1915–1918

  42. 42.

    Yang TJ, Chandler JP and Dunne-Anway S (1987) Growth stage-dependent expression of MHC antigens on the canine transmissible venereal sarcoma. Br J Cancer 55: 131–134

Download references

Author information

Correspondence to Tsu-Ju Yang.

Additional information

Supported by grants from the American Kennel Club, National Institutes of Health (CA23 469) and Funds for Research on Canine Diseases provided by the 1963 Connecticut Legislature

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yang, T., Palker, T.J. & Harding, M.W. Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma. Cancer Immunol Immunother 33, 255–262 (1991). https://doi.org/10.1007/BF01744945

Download citation

Keywords

  • Sarcoma
  • Tumor Volume
  • Immunosorbent Assay
  • Tumor Burden
  • Tumor Antigen